Fulcrum Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
FULC Key Statistics
Stock Snapshot
As of today, Fulcrum Therapeutics(FULC) shares are valued at $12.90. The company's market cap stands at 702.73M, with a P/E ratio of -11.02.
On 2025-12-13, Fulcrum Therapeutics(FULC) stock traded between a low of $12.58 and a high of $13.19. Shares are currently priced at $12.90, which is +2.5% above the low and -2.2% below the high.
The Fulcrum Therapeutics(FULC)'s current trading volume is 1.63M, compared to an average daily volume of 4.25M.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
FULC News
Fulcrum Therapeutics (FULC) announced that it has commenced an underwritten public offering of $150M of shares of its common stock. All of the shares in the pro...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Fulcrum Therapeutics (FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickl...
